Subsequent studies [2] showed that HE4 was very highly expressed in ovarian cancer but barely expressed in normal ovarian epithelium, which made it an ideal candidate marker for ovarian cancer with approval for its use in a clinical application [4]. Here, WFDC2 is linked to ovarian cancer.